![]() |
市場調查報告書
商品編碼
2046336
肩關節關節重建市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、手術方式、最終用戶、地區和競爭格局分類,2021-2031年Shoulder Replacement Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Procedure, By End-User, By Region & Competition, 2021-2031F |
||||||
全球肩關節關節重建市場預計將從 2025 年的 20.8 億美元大幅成長至 2031 年的 32.6 億美元,複合年成長率為 7.78%。
肩關節置換術是一種外科手術,透過手術切除肩肱關節受損的骨頭和軟骨,並用人工關節進行替換,旨在恢復活動能力並緩解疼痛。此手術的成長主要受全球人口快速老化以及骨關節炎盛行率不斷上升的推動,而保守治療無效後,骨關節炎患者往往需要手術介入。此外,運動相關損傷和創傷的增加也持續推動了手術數量的成長,從而形成了基本的市場需求。然而,該領域也面臨許多挑戰,例如術後併發症,包括植入鬆動和感染疾病,這些併發症可能需要昂貴的翻修手術,並成為患者接受手術的阻礙因素。患者的合併症會進一步加劇這些臨床風險。例如,根據美國整形外科學會(AAOS)發布的《2025年肩肘關節登記年度報告》,接受肩關節關節重建的患者中有51.2%為肥胖患者,這是外科醫師必須控制的重要因素,以確保植入長期有效。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 20.8億美元 |
| 市場規模:2031年 | 32.6億美元 |
| 複合年成長率:2026-2031年 | 7.78% |
| 成長最快的細分市場 | 表面置換關節重建 |
| 最大的市場 | 北美洲 |
全球肩關節關節重建市場正受到機器人輔助手術系統引入的顯著影響,這些系統提高了植入的精確度,並降低了再次手術的發生率。外科醫生擴大採用這些先進平台進行高度精確的術前規劃,確保肩胛盂組件的最佳放置,這對於植入的長期耐用性至關重要。這項技術進步是推動相容的高科技植入系統銷售的關鍵商業性催化劑。在2025年10月發布的第三季公佈財報中,史賽克公司報告其上肢業務部門實現了強勁的兩位數有機銷售成長,並將這一業績直接歸功於市場對其先進手術解決方案的持續需求。
此外,肩迴旋肌斷裂和運動相關損傷的日益普遍推動了市場擴張,這些損傷越來越需要手術干預,尤其是反向全肩關節置換術。隨著活躍人口的老化,複雜性肩迴旋肌斷裂的發生率激增,關節重建正逐漸從最後的選擇轉變為首選治療方法。大規模註冊數據也支持這一趨勢。美國整形外科會(AAOS)於2025年10月發布的肩肘關節註冊年度報告顯示,在分析的27,461例肩關節關節重建中,肩迴旋肌斷裂是第二大常見原發性診斷。同時,美國國家關節註冊中心於2025年9月發布的第22份年度報告強調了已開發地區手術操作的穩定性,記錄了在最近一個報告期間內進行的9,809例關節重建。
術後併發症,尤其是植入鬆動和感染疾病,是全球肩關節關節重建市場發展的重大障礙。這些臨床失敗不僅影響患者復健和長期療效,還會導致翻修手術,而重新置換手術技術難度更高,費用也更高。這些不利事件帶來的巨大經濟和身體負擔會對潛在患者造成心理障礙,常常導致他們即使關節疼痛難耐也延遲甚至放棄手術。因此,器械故障的固有風險降低了原本有效的假體解決方案的普及率,阻礙了市場擴張。
肩關節關節重建手術數量龐大,進一步加劇了這個問題的嚴重性。即使併發症率較低,翻修手術的絕對數量仍然相當可觀,這對醫療資源造成了巨大壓力。例如,根據美國國家關節登記處2025年第22份年度報告,上一年度共提交了9809例肩關節手術的分析數據。隨著手術數量的持續成長,對植入長期存活率的累積需求日益增加,這構成了一項重大阻礙因素。這種經濟壓力直接阻礙了市場成長,因為它將重要的資金和手術資源從新的成長機會中轉移出去。
由於門診和日間手術中心(ASC)的迅速發展,肩關節關節重建手術領域正經歷重大變革。這項轉變的驅動力來自疼痛管理技術的進步以及保險公司提供的優惠獎勵。隨著醫療服務提供者越來越傾向於選擇經濟高效的環境進行關節重建手術,這項變革代表著策略轉型。領先的醫療機構營運商積極拓展其整形外科服務項目,其業績也清楚地體現了這種模式的營運和財務優勢。例如,Surgery Partners在2025年11月發布的第三季公佈財報中指出,其門診手術中心在2025年第三季的全關節關節重建手術量增加了16%,凸顯了手術模式正迅速從傳統醫院環境轉移到非傳統模式。
同時,3D列印個人化植入和手術器械的出現和廣泛應用,正透過克服傳統現成人工關節的局限性,徹底改變解剖重組。製造商正利用積層製造技術生產高度多孔的鈦結構,這些結構能夠忠實地模擬天然骨骼,從而提高生物相容性並確保卓越的長期植入穩定性。隨著外科醫生對複雜肩胛盂畸形的個人化解決方案的需求日益成長,這項技術進步已成為推動商業性成長的關鍵因素。根據Enobis公司於2025年2月發布的2024年第四季度及全年財務報告,該公司重組部門的銷售額成長了59%,這一成長直接歸功於成功戰略收購並整合了Lima公司先進的3D列印植入產品組合。
The Global Shoulder Replacement Market is projected to expand significantly, from USD 2.08 Billion in 2025 to USD 3.26 Billion by 2031, demonstrating a 7.78% Compound Annual Growth Rate. Shoulder arthroplasty, the surgical removal and prosthetic replacement of damaged bone and cartilage in the glenohumeral joint, aims to restore mobility and alleviate pain. This growth is primarily fueled by a rapidly aging global population and the increasing incidence of osteoarthritis requiring surgical intervention after conservative treatments fail. Additionally, a rise in sports-related injuries and trauma consistently contributes to higher procedural volumes, establishing a fundamental market demand. However, the sector faces challenges from post-operative complications such as implant loosening and infection, which can necessitate costly revision surgeries and deter patient adoption. These clinical risks are further complicated by patient comorbidities; for instance, the American Academy of Orthopaedic Surgeons' 2025 Shoulder & Elbow Registry Annual Report indicated that 51.2% of shoulder arthroplasty patients were obese, a crucial factor surgeons must manage for successful long-term implant outcomes.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.08 Billion |
| Market Size 2031 | USD 3.26 Billion |
| CAGR 2026-2031 | 7.78% |
| Fastest Growing Segment | Resurfacing Hemiarthroplasty |
| Largest Market | North America |
Market Driver
The Global Shoulder Replacement Market is significantly influenced by the integration of robotic-assisted surgical systems, which enhance implant placement accuracy and reduce the incidence of revision surgeries. Surgeons are increasingly adopting these advanced platforms for highly precise pre-operative planning, ensuring optimal positioning of the glenoid component, which is vital for long-term implant durability. This technological advancement serves as a substantial commercial catalyst, boosting the sales of compatible high-tech implant systems. Stryker Corporation, in its October 2025 Q3 earnings call, reported robust double-digit organic sales growth in its Upper Extremities business, directly attributing this performance to sustained market demand for its advanced surgical solutions.
Furthermore, the market's expansion is driven by the growing prevalence of rotator cuff tears and sports-related injuries, which increasingly necessitate surgical intervention, particularly reverse total shoulder arthroplasty. As active demographics age, the incidence of complex cuff tear arthropathy has surged, establishing replacement surgery as a primary treatment rather than a last resort. This trend is corroborated by large-scale registry data; the American Academy of Orthopaedic Surgeons' October 2025 Shoulder & Elbow Registry Annual Report identified rotator cuff tears as the second leading primary diagnosis among 27,461 analyzed shoulder arthroplasty procedures. Concurrently, the National Joint Registry's September 2025 22nd Annual Report underscored procedural stability in developed regions, documenting 9,809 shoulder replacement procedures during its latest reporting period.
Market Challenge
Post-operative complications, specifically implant loosening and periprosthetic infections, pose a significant impediment to the growth of the global shoulder replacement market. These clinical failures not only compromise patient recovery and long-term outcomes but also necessitate technically complex and considerably more expensive revision arthroplasty. The substantial financial and physical burden associated with such adverse events creates a psychological disincentive for potential candidates, often leading them to delay or entirely forgo surgery despite experiencing debilitating joint pain. Consequently, the market's expansion is hampered as the inherent risks of device failure reduce the adoption rates of otherwise effective prosthetic solutions.
The magnitude of this issue is amplified by the sheer volume of shoulder replacement procedures performed; even a low complication rate translates into a considerable absolute number of revisions, thereby straining healthcare resources. For instance, the National Joint Registry's 2025 22nd Annual Report revealed that 9,809 shoulder procedures were submitted for analysis in the preceding calendar year. As such high procedural volumes continue to climb, the cumulative demand for managing long-term implant survivorship acts as a critical constraint. This economic pressure directly hinders market growth by reallocating crucial funds and surgical capacity away from new growth opportunities.
Market Trends
The shoulder arthroplasty landscape is undergoing a significant transformation due to the rapid adoption of procedures performed in outpatient and ambulatory surgery centers (ASCs), a shift propelled by advancements in pain management techniques and favorable payer incentives. This change represents a strategic redirection as healthcare providers increasingly favor cost-effective, high-efficiency settings for joint replacement. The operational and financial benefits of this model are evident in the performance of leading facility operators aggressively expanding their orthopedic service lines; for example, Surgery Partners reported a 16% growth in total joint surgeries within its ASC facilities during the third quarter of 2025, according to its November 2025 Q3 earnings call, highlighting the accelerated migration of procedures away from traditional hospital environments.
Concurrently, the emergence and proliferation of 3D-printed patient-specific implants and instrumentation are revolutionizing anatomical reconstruction by overcoming the limitations of conventional off-the-shelf prosthetics. Manufacturers are leveraging additive manufacturing to produce highly porous titanium structures that closely mimic natural bone, thereby improving biologic fixation and ensuring superior long-term implant stability. This technological evolution is a significant driver of commercial growth, as surgeons increasingly seek personalized solutions for complex glenoid deformities. Enovis Corporation's February 2025 report on its Fourth Quarter and Full Year 2024 Results indicated a 59% reported sales growth in its Reconstructive segment, a surge directly linked to the strategic acquisition and successful integration of LimaCorporate's advanced 3D-printed implant portfolio.
Report Scope
In this report, the Global Shoulder Replacement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Shoulder Replacement Market.
Global Shoulder Replacement Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: